BTK/JAK3 targeting therapeutics (Beijing Hanmi Pharmaceutical)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameBTK/JAK3 targeting therapeutics (Beijing Hanmi Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 modulatorsTyrosine-protein kinase BTK modulators
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase BTK
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Hanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Hanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A